Balchem Corporation Q1 2026 Earnings Release - Record Sales and Earnings Growth

Balchem Corporation reported strong first quarter 2026 financial results with record performance across key metrics. The company achieved net sales of $270.7 million, representing an 8.1% increase compared to the prior year quarter. Net earnings grew 8.7% to $40.3 million, while adjusted EBITDA increased 12.1% to $74.3 million. All three business segments showed growth: Human Nutrition & Health (8.3% sales increase), Animal Nutrition & Health (8.6% sales increase), and Specialty Products (4.4% sales increase). The company generated $40.1 million in operating cash flow and $33.8 million in free cash flow. Management highlighted the strength of their business model amid geopolitical uncertainties and released their 2025 Sustainability Report. The filing also announced an upcoming quarterly conference call for investors.